Correction of proliferation and drug sensitivity defects in the progeroid Werner's syndrome by holliday junction resolution

Rejuvenation Research

Volumn 10, Issue 1, 2007, Pages 27-40

  Rodriguez Lopez, Ana M ^a,b   Whitby, Matthew C ^a   Borer, Christine M ^a   Bachler, Marcus A ^a   Cox, Lynne S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CAMPTOTHECIN; CISPLATIN; DNA; EXONUCLEASE; HELICASE;

AGING; ARTICLE; CELL CYCLE S PHASE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DNA RECOMBINATION; DNA REPLICATION; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; FEMALE; FIBROBLAST; GENETIC STABILITY; HOLLIDAY JUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; WERNER SYNDROME;

CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; DNA, CRUCIFORM; FIBROBLASTS; HOLLIDAY JUNCTION RESOLVASES; HUMANS; WERNER SYNDROME;

BACTERIA (MICROORGANISMS);

EID: 33947401804     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2006.0503     Document Type: Article

References (74)

1. Epstein CJ, Martin GM, Schultz AL, Motulsky AG. Werner's syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966;45(3):177-221.
2. Martin GM. Genetics and aging; the Werner syndrome as a segmental progeroid syndrome. Adv Exp Med Biol 1985;190:161-170.
3. Salk DK, Au K, Hoehn AH, Martin GM. Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mpsaicism. Cytogenet Cell Genet 1981;30(2):92-107.
4. Foot M, Hoehn H, Runger TM, Martin GM. Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp Cell Res 1992; 202(2):267-273.
5. Rodriguez-Lopez AM, Jackson DA, Iborra F, Cox LS. Asymmetry of DNA replication fork progression in Werner's syndrome. Aging Cell 2002;1(1):30-39.
6. Saintigny Y, Makienko K, Swanson C, Emond MJ, Monnat RJ Jr. Homologous recombination resolution defect in werner syndrome. Mol Cell Biol 2002;22(20): 6971-6978.
7. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD. Positional cloning of the Werner's syndrome gene. Science 1996;272(5259):258-262.
8. Gray MD, Shen JC, Kamath-Loeb AS, Blank A, Sopher BL, Martin GM, Oshima J, Loeb LA. The Werner syndrome protein is a DNA helicase. Nat Genet 1997;17(1):100-103.
9. Huang S, Li B, Gray MD, Oshima J, Mian IS, Campisi J. The premature ageing syndrome protein, WRN, is a 3′ → 5′ exonuclease. Nat Genet 1998;20(2):114-116.
10. Kamath-Loeb AS, Shen JC, Loeb LA, Fry M. Werner syndrome protein. II. Characterization of the integral 3′ → 5′ DNA exonuclease. J Biol Chem 1998;273(51): 34145-34150.
11. Suzuki N, Shiratori M, Goto M, Furuichi Y. Werner syndrome helicase contains a 5′ → 3′ exonuclease activity that digests DNA and RNA strands in DNA/ DNA and RNA/DNA duplexes dependent on unwinding. Nucleic Acids Res 1999;27(11):2361-2368.
12. Opresko PL, Cheng WH, Bohr VA. Junction of RecQ helicase biochemistry and human disease. J Biol Chem 2004;279(18):18099-18102.
13. Bachrati CZ, Hickson ID. RecQ helicases: suppressors of tumorigenesis and premature aging. Biochem J 2003;374(Pt 3)577-606.
14. Fry M, Loeb LA. Human werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n. J Biol Chem 1999;274(18):12797-12802.
15. Constantinou A, Tarsounas M, Karow JK, Brosh RM, Bohr VA, Hickson ID, West SC. Werner's syndrome protein (WRN) migrates Holliday junctions and colocalizes with RPA upon replication arrest. EMBO Rep 2000;1(1):80-84.
16. Yamagata K, Kato J, Shimamoto A, Goto M, Furuichi Y, Ikeda H. Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases. Proc Natl Acad Sci USA 1998;95(15):8733-8738.
17. Prince PR, Emond MJ, Monnat RJ Jr. Loss of Werner syndrome protein function promotes aberrant mitotic recombination. Genes Dev 2001;15(8):933-938.
18. Bennett SE, Umar A, Oshima J, Monnat RJ Jr, Kunkel TA. Mismatch repair in extracts of Werner syndrome cell lines. Cancer Res 1997;57(14):2956-2960.
19. Harrigan JA, Wilson DM 3rd, Prasad R, Opresko PL, Beck G, May A, Wilson SH, Bohr VA. The Werner syndrome protein operates in base excision repair and cooperates with DNA polymerase beta. Nucleic Acids Res 2006;34(2):745-754.
20. Chen L, Huang S, Lee L, Davalos A, Schiestl RH, Campisi J, Oshima J. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell 2003;2(4): 191-199.
21. Zhang N, Kaur R, Lu X, Shen X, Li L, Legerski RJ. The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand cross-links. J Biol Chem 2005;280(49):40559-40567.
22. Laud PR, Multani AS, Bailey SM, Wu L, Ma J, Kingsley C, Lebel M, Pathak S, DePinho RA, Chang S. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev 2005;19(21):2560-2570.
23. Pichierri P, Franchitto A, Mosesso P, Palitti F. Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol Biol Cell 2001; 12(8):2412-2421.
24. Cobb JA, Schleker T, Rojas V, Bjergbaek L, Tercero JA, Gasser SM. Replisome instability, fork collapse, and gross chromosomal rearrangements arise synergistically from Mec1 kinase and RecQ helicase mutations. Genes Dev 2005;19(24):3055-3069.
25. Okada M, Goto M, Furuichi Y, Sugimoto M. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol Pharm Bull 1998;21(3):235-239.
26. Foot M, Gollahon KA, Rabinovitch PS. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum Genet 1999;104(1):10-14.
27. Foot M, Gollahon KA, Emond MJ, Silber JR, Rabinovitch PS. Werner syndrome diploid fibroblasts are sensitive to 4-nitroquinoline-N-oxide and 8-methoxy-psoralen: implications for the disease phenotype. FASEB J 2002;16(7):757-758.
28. Lebel M, Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular replicative capacity. Proc Natl Acad Sci USA 1998;95:13097-13102.
29. Ogburn CE, Oshima J, Foot M, Chen R, Hunt KE, Gollahon KA, Rabinovitch PS, Martin GM. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet 1997;101(2):121-125.
30. Pichierri P, Franchitto A, Mosesso P, Palitti F. Werner's syndrome cell lines are hypersensitive to camptothecin-induced chromosomal damage. Mutat Res 2000;456(1-2):45-57.
31. Mankouri HW, Morgan A. The DNA helicase activity of yeast Sgs1p is essential for normal lifespan but not for resistance to topoisomerase inhibitors. Mech Ageing Dev 2001;122(11):1107-1120.
32. Doe CL, Ahn JS, Dixon J, Whitby MC. Mus81-Eme1 and Rqh1 involvement in processing stalled and collapsed replication forks. J Biol Chem 2002;277(36): 32753-32759.
33. Watt PM, Louis JE, Borts RH, Hickson ID. Sgs1: a eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation. Cell 1995;81(2):253-260.
34. Win TZ, Mankouri HW, Hickson ID, Wang SW. A role for the fission yeast Rqh1 helicase in chromosome segregation. J Cell Sci 2005;118(Pt 24)5777-5784.
35. Sharples GJ, Chan SN, Mahdi AA, Whitby MC, Lloyd RG. Processing of intermediates in recombination and DNA repair: identification of a new endonuclease that specifically cleaves Holliday junctions. EMBO J 1994; 13:6133-6142.
36. Chan SN, Harris L, Bolt EL, Whitby MC, Lloyd RG. Sequence specificity and biochemical characterization of the RusA Holliday junction resolvase of Escherichia coli. J Biol Chem 1997;272(23):14873-14882.
37. Bolt EL, Sharples GJ, Lloyd RG. Identification of three aspartic acid residues essential for catalysis by the RusA holliday junction resolvase. J Mol Biol 1999; 286(2):403-415.
38. Doe CL, Dixon J, Osman F, Whitby MC. Partial suppression of the fission yeast rqh1(-) phenotype by expression of a bacterial Holliday junction resolvase. EMBO J 2000;19(11):2751-2762.
39. Faragher RG, Kill IR, Hunter JA, Pope FM, Tannock C, Shall S. The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc Natl Acad Sci USA 1993;90(24):12030-12034.
40. Kill IR, Faragher RG, Lawrence K, Shall S. The expression of proliferation-dependent antigens during the lifespan of normal and progeroid human fibroblasts in culture. J Cell Sci 1994;107(Pt 2)571-579.
41. Fukuchi K, Tanaka K, Nakura J, Kumahara T, Uchida T, Okada Y. Elevated spontaneous mutation rate in SV40-transformed Werner syndrome fibroblast cell lines. Somat Cell Mol Genet 1985;11(4):303-308.
42. Hisama FM, Chen YH, Meyn MS, Oshima J, Weissman SM. WRN or telomerase constructs reverse 4-nitroquinoline 1-oxide sensitivity in transformed Werner syndrome fibroblasts. Cancer Res 2000;60(9): 2372-2376.
43. Gebhart E, Bauer R, Raub U, Schinzel M, Ruprecht KW, Jonas JB. Spontaneous and induced chromosomal instability in Werner syndrome. Hum Genet 1988;80(2):135-139.
44. Nunoshiba T, Demple B. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide. Cancer Res 1993;53(14):3250-3252.
45. Tada M. Main binding sites of the carcinogen, 4-nitroquinoline 1-oxide in nucleic acids. Biochim Biophys Acta 1976;454(3):558-566.
46. Panigrahi GB, Walker IG. The N2-guanine adduct but not the C8-guanine or N6-adenine adducts formed by 4-nitroquinoline 1-oxide blocks the 3′-5′ exonuclease action of T4 DNA polymerase. Biochemistry 1990; 29(8):2122-2126.
47. Tohme N, Demeunynck M, Lhomme MF, Lhomme J. Formation of a cyclic adenine adduct with a 4-nitroquinoline N-oxide metabolite model. IARC Sci Publ 1986(70):241-245.
48. Rodolfo C, Lanza A, Tornaletti S, Fronza G, Pedrini AM. The ultimate carcinogen of 4-nitroquinoline 1-oxide does not react with Z-DNA and hyperreacts with B-Z junctions. Nucleic Acids Res 1994;22(3): 314-320.
49. Shao RG, Cao CX, Zhang H, Kohn KW, Wold MS, Pommier Y. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J 1999;18(5):1397-1406.
50. Cox MM, Goodman MF, Kreuzer KN, Sherratt DJ, Sandler SJ, Marians KJ. The importance of repairing stalled replication forks. Nature 2000;404(6773):37-41.
51. Lambert S, Watson A, Sheedy DM, Martin B, Carr AM. Gross chromosomal rearrangements and elevated recombination at an inducible site-specific replication fork barrier. Cell 2005;121:689-702.
52. Ahn JS, Osman F, Whitby MC. Replication fork blockage by RTS1 at an ectopic site promotes recombination in fission yeast. EMBO J 2005;24(11):2011-2023.
53. Hope JC, Mense SM, Jalakas M, Mitsumoto J, Freyer GA. Rqh1 blocks recombination between sister chromatids during double strand break repair, independent of its helicase activity. Proc Natl Acad Sci USA 2006;103(15):5875-5880.
54. Cobb JA, Bjergbaek L, Shimada K, Frei C, Gasser SM. DNA polymerase stabilization at stalled replication forks requires Mec1 and the RecQ helicase Sgs1. EMBO J 2003;22(16):4325-4336.
55. Santocanale C, Diffley JF. A Mec1- and Rad53-dependent checkpoint controls late-firing origins of DNA replication. Nature 1998;395(6702):615-618.
56. Cotta-Ramusino C, Fachinetti D, Lucca C, Doksani Y, Lopes M, Sogo J, Foiani M. Exo1 processes stalled replication forks and counteracts fork reversal in checkpoint-defective cells. Molecular Cell 2005;17: 153-159.
57. Lopes M, Cotta-Ramusino C, Pellicioli A, Liberi G, Plevani P, Muzi-Falconi M, Newlon CS, Foiani M. The DNA replication checkpoint response stabilizes stalled replication forks. Nature 2001;412:557-561.
58. Sogo JM, Lopes M, Foiani M. Fork reversal and ss-DNA accumulation at stalled replication forks owing to checkpoint defects. Science 2002;297:599-602.
59. Tercero JA, Diffley JF. Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint. Nature 2001;412:553-557.
60. Frei C, Gasser SM. The yeast Sgs1p helicase acts up-stream of Rad53p in the DNA replication checkpoint and colocalizes with Rad53p in S-phase-specific foci. Genes Dev 2000;14(1):81-96.
61. Cobb JA, Bjergbaek L, Gasser SM. RecQ helicases: at the heart of genetic stability. FEBS Lett 2002;529(1): 43-48.
62. Liberi G, Maffioletti G, Lucca C, Chiolo I, Baryshnikova A, Cotta-Ramusino C, Lopes M, Pellicioli A, Haber JE, Foiani M. Rad51-dependent DNA structures accumulate at damaged replication forks in sgs1 mutants defective in the yeast ortholog of BLM RecQ helicase. Genes Dev 2005;19(3):339-350.
63. Pichierri P, Rosselli F, Franchitto A. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle. Oncogene 2003;22(10):1491-1500.
64. Rodriguez-Lopez AM, Jackson DA, Nehlin JO, Iborra F, Warren AV, Cox LS. Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA. Mech Ageing Dev 2003;124(2):167-174.
65. Cheng WH, von Kobbe C, Opresko PL, Arthur LM, Komatsu K, Seidman MM, Carney JP, Bohr VA. Linkage between Werner syndrome protein and the Mre11 complex via Nbs1. J Biol Chem 2004;279(20):21169-21176.
66. Franchitto A, Pichierri P. Werner syndrome protein and the MRE11 complex are involved in a common pathway of replication fork recovery. Cell Cycle 2004; 3(10):1331-1339.
67. Pichierri P, Franchitto A. Werner syndrome protein, the MRE11 complex and ATR: menage-a-trois in guarding genome stability during DNA replication? Bioessays 2004;26(3):306-313.
68. Sharma S, Otterlei M, Sommers JA, Driscoll HC, Dianov GL, Kao HI, Bambara RA, Brosh RM Jr. WRN helicase and FEN-1 form a complex upon replication arrest and together process branchmigrating DNA structures associated with the replication fork. Mol Biol Cell 2004;15(2):734-750.
69. Laursen LV, Ampatzidou E, Andersen AH, Murray JM. Role for the fission yeast RecQ helicase in DNA repair in G2. Mol Cell Biol 2003;23(10):3692-3705.
70. Zhang R, Sengupta S, Yang Q, Linke SP, Yanaihara N, Bradsher J, Blais V, McGowan CH, Harris CC. BLM helicase facilitates Mus81 endonuclease activity in human cells. Cancer Res 2005;65(7):2526-2531.
71. Whitby MC, Osman F, Dixon J. Cleavage of model replication forks by fission yeast Mus81-Eme1 and budding yeast Mus81-Mms4. J Biol Chem 2003;278(9): 6928-6935.
72. Davis T, Baird DM, Haughton MF, Jones CJ, Kipling D. Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J Gerontol A Biol Sci Med Sci 2005;60(11): 1386-1393.
73. Brooks-Wilson AR, Emond MJ, Monnat RJ Jr. Unexpectedly low loss of heterozygosity in genetically unstable Werner syndrome cell lines. Genes Chromosomes Cancer 1997;18(2):133-142.
74. Fukuchi K, Martin GM, Monnat RJ Jr. Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc Natl Acad Sci USA 1989;86(15): 5893-5897.